Geoffrey is a associate director  in the corporate team who specializes in mergers and acquisitions, venture capital, private equity investments and joint ventures.

He has a particular focus on the Tech, Media and Comms and Life Science & Healthcare and Financial Services sectors with experience acting for a wide range of clients. Geoffrey also has broad experience with assisting start-up companies on both commercial, corporate law matters and financing rounds.

Geoffrey joined Osborne Clarke in 2016 from international law firm Bird & Bird. He successfully completed the post-graduate course National and International Contracts at the Grotius Academy in 2015.

Work

DSM Venturing

Advised DSM Venturing on the $47 million Series A funding round in innovative food company, Meatable. Read more >

Wireless Logic Holding

Advised Wireless Logic Group, Europe’s leading Internet of Things (IoT) connectivity platform provider on the acquisition of New Line Mobile, read more.

 

Wireless Logic Holding

Advised Wireless Logic Holding on acquisition of SIMPoint. Read more >

Breath Therapeutics

Advised on the sale of Breath Therapeutics to Zambon, read more.

MediaMonks

Advised the owners of MediaMonks on its sale to S4 Capital, read more.

EQT Ventures

Advised EQT Ventures with the investment in Siilo, a secure mobile messaging service bringing medical teams together.

ViroClinics

Represented Gilde Healthcare and key management (sellers) in the auction sale of ViroClinics Biosciences B.V. to Parcom Capital, a leading mid-market private equity firm in the Benelux, as well key management in their continuing investment in ViroClinics post-closing.

Bioclin Therapeutics

Represented new investors INKEF Capital and Sectoral Asset Management as well as existing investors Sofinnova Ventures and Ysios Capital in respect of the USD 50 million Series B financing round of BioClin Therapeutics. Other investors include HealthCap, Tekla Capital Management funds and Life Sciences Partners (LSP). Read more

Lava Therapeutics

Advised a syndicate of investors led by Gilde Healthcare and Versant Ventures with additional support from US-based MRL Ventures Fund in the EUR 16 million financing round of Lava Therapeutics, read more

Calco Group

Assisted shareholders with the sale to Inflexion Private Equity of Calco Group B.V. (“Calco”), a leading Dutch provider of  IT recruitment and training services and specialised in staffing of junior IT personnel to large blue-chip corporates, operating primarily within the finance and insurance sectors with clients including the main banks and the top insurance companies in the Netherlands.

A-Gas

Advised A-Gas on the acquisition of Netherlands' reclamation business BTC.

Breath Therapeutics

Represented Breath Therapeutics on EUR 43.5m Series A financing round by Gimv, Sofinnova Partners and Gilde Healthcare.

Sofinnova Ventures & Ysios Capital

Represented Sofinnova Ventures and Ysios Capital as lead investors in the USD 30 million Series B Financing round of BioClin Therapeutics.